Ultra-Short-Course Seasonal Allergy Vaccine (Pollinex® Quattro)

@article{Jutel2012UltraShortCourseSA,
  title={Ultra-Short-Course Seasonal Allergy Vaccine (Pollinex® Quattro)},
  author={Marek Jutel},
  journal={Drugs},
  year={2012},
  volume={66},
  pages={939-939}
}
allergoids (glutaraldehyde-modified allergens, Ultra-Short-Course Seasonal which do not bind IgE) and the adjuvant 3-deacylatAllergy Vaccine (Pollinex® ed monophosphoryl lipid A (MPL®) derived from Quattro) bacterial cell walls. Although its mechanism of acA Viewpoint by Marek Jutel tion is still unclear, MPL® helps to shift the immune response to allergens from a T-helper type 2 (Th2) to Department of Internal Medicine and a Th1 cytokine profile, without having the toxic Allergology, Wroclaw… CONTINUE READING